Blaise Coleman - Jun 5, 2025 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Blaise Coleman by Shankar Musunuri, his attorney-in-fact
Stock symbol
OCGN
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/9/2025, 05:19 PM
Previous filing
Mar 31, 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Blaise Director C/O OCUGEN, INC., 11 GREAT VALLEY PARKWAY, MALVERN /s/ Blaise Coleman by Shankar Musunuri, his attorney-in-fact 2025-06-09 0001689280

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +151K $0.00 151K Jun 5, 2025 Common Stock 151K $0.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests monthly in equal installments over three years commencing on July 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date.